314 related articles for article (PubMed ID: 8546899)
1. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
[TBL] [Abstract][Full Text] [Related]
2. Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP.
Lewis JW; Neisig A; Neefjes J; Elliott T
Curr Biol; 1996 Jul; 6(7):873-83. PubMed ID: 8805302
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
[TBL] [Abstract][Full Text] [Related]
4. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.
Vora AR; Rodgers S; Parker AJ; Start R; Rees RC; Murray AK
Br J Cancer; 1997; 76(7):836-44. PubMed ID: 9328140
[TBL] [Abstract][Full Text] [Related]
6. Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival.
Lou Y; Vitalis TZ; Basha G; Cai B; Chen SS; Choi KB; Jeffries AP; Elliott WM; Atkins D; Seliger B; Jefferies WA
Cancer Res; 2005 Sep; 65(17):7926-33. PubMed ID: 16140964
[TBL] [Abstract][Full Text] [Related]
7. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.
Cromme FV; Airey J; Heemels MT; Ploegh HL; Keating PJ; Stern PL; Meijer CJ; Walboomers JM
J Exp Med; 1994 Jan; 179(1):335-40. PubMed ID: 8270878
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma.
Seliger B; Dunn T; Schwenzer A; Casper J; Huber C; Schmoll HJ
Scand J Immunol; 1997 Dec; 46(6):625-32. PubMed ID: 9420627
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide binding by TAP mediates association with peptide and release of assembled MHC class I molecules.
Knittler MR; Alberts P; Deverson EV; Howard JC
Curr Biol; 1999 Sep; 9(18):999-1008. PubMed ID: 10508608
[TBL] [Abstract][Full Text] [Related]
10. MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.
Garcia-Lora A; Martinez M; Algarra I; Gaforio JJ; Garrido F
Int J Cancer; 2003 Sep; 106(4):521-527. PubMed ID: 12845647
[TBL] [Abstract][Full Text] [Related]
11. Investigation of HLA class I downregulation in breast cancer by RT-PCR.
Palmisano GL; Pistillo MP; Capanni P; Pera C; Nicolò G; Salvi S; Perdelli L; Pasciucco G; Ferrara GB
Hum Immunol; 2001 Feb; 62(2):133-9. PubMed ID: 11182222
[TBL] [Abstract][Full Text] [Related]
12. Mutation in the beta 2m gene is not a frequent event in head and neck squamous cell carcinomas.
Feenstra M; Rozemuller E; Duran K; Stuy I; van den Tweel J; Slootweg P; de Weger R; Tilanus M
Hum Immunol; 1999 Aug; 60(8):697-706. PubMed ID: 10439315
[TBL] [Abstract][Full Text] [Related]
13. Assembly of tapasin-associated MHC class I in the absence of the transporter associated with antigen processing (TAP).
Paulsson KM; Anderson PO; Chen S; Sjögren HO; Ljunggren HG; Wang P; Li S
Int Immunol; 2001 Jan; 13(1):23-9. PubMed ID: 11133831
[TBL] [Abstract][Full Text] [Related]
14. External glycopeptide binding to MHC class-I in relation to expression of TAP transporters, beta 2-microglobulin and to pH.
Abdel-Motal UM; Dahmén J; Liu T; Ljunggren HG; Jondal M
Immunol Lett; 1996 Dec; 54(1):31-5. PubMed ID: 9030979
[TBL] [Abstract][Full Text] [Related]
15. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines.
Singal DP; Ye M; Ni J; Snider DP
Immunol Lett; 1996 May; 50(3):149-54. PubMed ID: 8803612
[TBL] [Abstract][Full Text] [Related]
16. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
[TBL] [Abstract][Full Text] [Related]
17. Distinct differences in association of MHC class I with endoplasmic reticulum proteins in wild-type, and beta 2-microglobulin- and TAP-deficient cell lines.
Paulsson KM; Wang P; Anderson PO; Chen S; Pettersson RF; Li S
Int Immunol; 2001 Aug; 13(8):1063-73. PubMed ID: 11470776
[TBL] [Abstract][Full Text] [Related]
18. HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis.
Bandoh N; Ogino T; Katayama A; Takahara M; Katada A; Hayashi T; Harabuchi Y
Oncol Rep; 2010 Apr; 23(4):933-9. PubMed ID: 20204276
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of peptide and major histocompatibility complex class I/beta 2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2).
Androlewicz MJ; Ortmann B; van Endert PM; Spies T; Cresswell P
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12716-20. PubMed ID: 7809108
[TBL] [Abstract][Full Text] [Related]
20. Crystal structures of two rat MHC class Ia (RT1-A) molecules that are associated differentially with peptide transporter alleles TAP-A and TAP-B.
Rudolph MG; Stevens J; Speir JA; Trowsdale J; Butcher GW; Joly E; Wilson IA
J Mol Biol; 2002 Dec; 324(5):975-90. PubMed ID: 12470953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]